Wisp introduces personalized, online consultations with access to four weight care solutions, including GLP-1 medications, to support women struggling with hormonal conditions such as perimenopause, menopause, Polycystic Ovary Syndrome (PCOS), and endometriosis
The observed reduction in AUD risk is particularly noteworthy given the global burden of AUD, which affects an estimated 280 million people and is associated with high morbidity and mortality [34]
doi: 10.1038/s41419-023-05716-0 125 PulkkinenKHYl-HerttualaSLevonenAL
They may offer a meaningful reduction in cravings and relapse risk across various addictive disorders." Dr Sophie Dix, Head of Medical Product and Content at Levity "GLP-1s appear to modulate activity in the mesolimbic dopamine system, the same circuitry implicated in both substance addiction and compulsive overeating
If you want more detail on real-world timelines, this tirzepatide 6-month weight loss overview is a helpful companion read
BPC-157 compares with other recovery options, as shown in the table below